Tag Archives: Martin Shkreli

Penis Aqua Rosa Congressista

The Dutch used to have interesting names for classifying people. There was ‘Penis jujubes’ (originally: Droplul), which amounts to Liquorice Penis, which captions the non-Dutch titles dick, asshole and idiot. The other one was ‘Penis Aqua Rosa’ (originally: Lulletje Rozewater), which gets us Rosewater Dick, which is an expression for a man that has no backbone, a man that is weak and submissive. The latter one seems to apply to the US Congress in a few ways.

You see, the  article ‘Drug company boss Martin Shkreli refuses to testify to Congress‘ gives us part of it all (at http://www.theguardian.com/business/2016/feb/04/martin-shkreli-refuses-to-testify-congress-drug-daraprim), an issue that might be seen in the wrong light, if you only go by the one side of the story. You see, this is situation that Congress and their US laws created for themselves. Even if we get the ’emotional’ statement: “One member begged him to examine his conscience“, we all seem to ignore, that this is something Congress achieved all by themselves. You see the quote “Earlier, Shkreli and Turing’s chief commercial officer, Nancy Retzlaff, were criticized for hiking the price of Daraprim despite the fact it is the only government-approved treatment for the rare infection toxoplasmosis, which can be fatal for some Aids and cancer patients and endangers babies in-utero” is at the core of this.

Instead of setting up the law that fairness was at the centre of it all, politicians set the speculation that every pharmaceutical company and their fields would be ‘distributed’, that there was no overlap (for the larger extent), as such pharmaceutical had a clear field for maximised profits. How long did you think it was going to take before someone weaselled themselves into that crowd, with the simple goal of maximising his Return-on-Investment? The United States of America has always been about capitalism and living the dream. Martin Shkreli is doing just that, now we get what some might call ‘sissy noises‘ from the Halls of Congress!

Let’s be Frank (or Punch and Judy; whatever works for you), what Martin Shkreli does is utterly unacceptable, yet, it is Congress that did not legislatively clip the wings of unbridled greed. They sat around as President Bill Clinton called for the end of the Glass–Steagall Legislation. As the majority remained silent additional doors to greed got opened. In all this, the lack of visionaries in Congress, even after 2008 lacked action when it came to protecting the citizens of the United States of America. So when I see the response from a member of congress “member begged him to examine his conscience“, I will kindly tell that congressperson to cry me a river and I’ll do so whilst playing worlds tiniest violin.

Congress is in an emotional state, suddenly crying for those who cannot afford it, yet what clear provisions in legislation has it given to the coffers of the United States? You see when we consider November 23rd (at http://www.forbes.com/sites/antoinegara/2015/11/23/pfizer-and-allergan-merger-ranks-as-biggest-ever-pharmaceutical-deal) and we see “On Monday, Pfizer PFE +0.10% and Allergan unveiled an all-stock merger that will allow the combined company, Pfizer PLC, to move its headquarters to Ireland and focus on corporate cost cuts“, which is set at $160 billion, you better believe that this impacts the taxability of that corporation by a lot. As far as I can tell from the surface, the total of pharmaceutical mergers LAST YEAR ALONE is well over 600 billion, so half a trillion dollars, all now going via Ireland. How much noise is congress making there? Or do these ‘respectful’ members of congress have a few too many friends in ‘those’ circles? Better to loudly focus on the one man out as Pfizer, Allergan and a few others. Can we all agree that the difference of 600 billion, being taxed at 25%, or being taxed at 17% is worth moving house over? You see, I love Sydney, but when someone tells me that moving will get me $48 billion, I will start singing ‘My heart is in Ireland‘ and I will enthusiastically pack my bags. You see, I can always get a second apartment in Buenos Aires and life of my self-made cash cow, getting me $50K a day and still allow me to double my fortune before I retire, making me live of $200K a day until I die. That is the track that Congress left open. This can be seen (at http://www.forbes.com/sites/antoinegara/2015/11/23/pfizer-and-allergan-merger-ranks-as-biggest-ever-pharmaceutical-deal), the quote there “move its headquarters to Ireland and focus on corporate cost cuts“, can be seen as ‘tax cuts’ and now guess what a chunk of those cost cuttings will go? You probably guessed it, the gents (ladies too) of the board of directors of Pfizer.

So, when I state to the person in Congress ‘go cry me a river’, I am being pretty serious. For the mere reason after all those hard words that the media published on how this was going to get stopped, on how some African American in a non-circular room (according to whitehouse.gov) decided to call for ‘Closing Corporate Tax Loopholes’ in July 26th 2014. I am guessing that this was unsuccessful as Pfizer basically walked out with well over half a trillion. The move started in November 2015 and the press has been absent of any failure to stop Pfizer from moving away from the American non-tax havens, towards the shores of paddy’s Irish Whiskey and the real tax havens.

Let’s be clear, that this does not excuse Martin Shkreli from the acts he is doing, or would it stop me from legislatively going after Martin Shkreli if I could. The mere reality is that it will be close to impossible to do because the US Congress had enabled much of what Martin Shkreli did, which is not what they intended to do, yet it is what is the non-emotional result, so in that matter ‘examine his conscience‘ applies to a much larger extent to Congress and its need to clean up the mess that allows corporate American to get around taxation. A mess congress might not be willing to fix for the simple speculation that when not re-elected those members of Congress need to rely on large corporations for their next pay check.

I am not the only one on this horse, as far as I can tell ‘the New Yorker’ and a few others are starting to realise that no matter how objectionable the acts of Martin Shkreli are, there is now a focal point change. This focal point is about how Congress itself is part of the problem, not part of anyone’s solution (at http://www.newyorker.com/culture/cultural-comment/everyone-hates-martin-shkreli-everyone-is-missing-the-point), how there is an unlabelled coffer with funds to buy items of survival for people who cannot afford it. The New Yorker states it as “mysterious corporate bargaining, and occasional charitable acts“, this includes (as I personally see it) Pfizer and their transplanted plus 600 billion, moving to Ireland.

So even when we consider the acts of Martin Shkreli to be vile and evil, how is the inaction of Congress not worse? How is it that we cannot condone the acts of a failed administration, whilst the acts of a person who was in it for the money from day one to be such a surprise?

A man that graduated from Bernard M. Baruch College of the City University of New York, who became a hedge funds manager, ‘evolved’ as an entrepreneur and who is living the American dream.

How are any of the unfolding elements a surprise to anyone?

 

Leave a comment

Filed under Finance, Law, Media, Politics

How to cure economic sickness

The Guardian is bringing me grim news today. As a British conservative and as an Australian Liberal the news presented does not look good, it is slightly beyond critical. It also reminds me of a small gag I heard in the Netherlands 3 decades ago. The one-liner was: “Due to a death, this cemetery will remain closed for the next few days” (source Fons Jansen), yes it seems like a laughing matter, but the Grimness behind it is less amusing and more dread based than we realise. The news ‘Ministers ‘are hiding details of £2bn NHS cash crisis’‘ (at http://www.theguardian.com/society/2015/oct/03/ministers-hiding-details-nhs-cash-crisis) is at the centre of all this. As a conservative my response (with all due respect) to Prime Minister David Cameron is ‘Sir, are you barking mad?‘ I will direct this at the Prime Minister because he is ‘our’ leader, the man in charge. If there is even the slightest hint that he was not aware than a massive reshuffle will be needed within the next 48 hours.

You see, I have forever opposed hiding bad news. Managing bad news will always bite the parties involved in the end. When the implied deficit amounts to 0.5% of all collected taxations in 2014, we have a massive problem which must be addressed and it needs to be addressed sooner rather than later. You see, no matter how trivial this 0.5% might seem. The coffers are down well over a trillion pounds, which requires 100% of all collected taxations for three years to address. Now that act is not realistic, but that show you the massive damage the United Kingdom faces. Economies are slowing down, partially due to Asia, partially due to acts that America is about to do and as such the American economy will soon take another tumble. As I see it, Thanksgiving and Christmas might hide the events, but the end of January through March, especially when the US Department of Defence will make 40,000 people redundant, that economy will shift over the following 4 months. In all this, the UK can no longer afford to hide bad news of this nature. The Commonwealth in general needs to realise that as the US seems to enable greed based corporations, we as members of the Commonwealth will have to stick together. This is no longer about national pride and ego. Our collective politicians are more likely to walk away with opportunities that will guarantee the well-being of their families for more than two generations, whilst in all this the people will end up getting saddled with a debt that will stop them from moving forward in any decent future for decades to come. None of us agreed to such imbalance.

The quote “Heidi Alexander, the shadow health secretary, said on Saturday: “This appears to be a cynical attempt to suppress bad news ahead of the Tory party conference. It makes a mockery of Tory claims to be committed to transparency in the NHS, and leaves Jeremy Hunt with very serious questions to answer. These figures must now be published in full as a matter of urgency”” gives weight to this. Part of me is also very cautious on her statement, let’s not forget that it was Labour that squandered 11 billion from the NHS and they have not been forthcoming at all, so let’s realise that this still remains an issue of the Pot calling the Kettle black.

The next part is set over two quotes. The first is “Professor Chris Ham, chief executive of the King’s Fund think tank, recently said that the NHS’s fast-ballooning deficit was leading to “panic” at the health department and “denial” at the Treasury. The service’s overspend was so large that it needed an emergency injection of £1bn in the comprehensive spending review to keep functioning, added Ham“, the second quote is “Without extra funding, he argued, the NHS would end up unable to cope, “most likely during the winter when many hospitals run out of money … With NHS hospitals unable to go bankrupt…, the Treasury will be forced to intervene or accept a rapid decline in performance.”“. The issue is in more than one part. In the first we must question how the NHS ended up short by 2 billion. We have heard all the wild accusations in the papers, but what news there has any reliability? No matter how little of it is true, Jeremy Hunt has an official problem, because if he has kept facts away from the public than he has no right being in his position, if he is falling on his sword for the party, we have an even larger issue. Because the conservative members feel that they should be told the facts, good or bad. We cannot fix when things remain hidden. We within the Commonwealth will become puppets to those operating the machines. It is a fake freedom which does do no one any good.

Yet the NHS has issues on several levels. One level was discussed in my blog article called ‘In Greed we trust‘ (at https://lawlordtobe.com/2015/09/22/in-greed-we-trust/). Here we looked at Turing Pharmaceuticals AG and the little caper they pulled on Daraprim. They weren’t the only ones. The Financial Post (at http://business.financialpost.com/investing/global-investor/valeant-pharmaceuticals-international-inc-shares-plummet-as-525-hike-in-drug-price-draws-fire) gave us “Valeant Pharmaceuticals International Inc. shares fell as much as 20 per cent after Democrats in the U.S. House asked to subpoena the company for documents relating to drug price increases, the latest move by politicians seeking to curb price hikes on acquired drugs“. When we see places like Turing Pharmaceuticals ‘hiding’ behind places like PrWeb and PrNewsWire, you better believe you are facing marketing from the bottom of the barrel. Yet in all this serious demands from the government looking into these companies who bought up niche medications and driving up prices by hundreds of percentage points is a matter this government (as well as the previous one) did not have to content with and as such the NHS will receive even more pressure. This is exactly why I have pushed for close to two years towards a stronger Commonwealth coalition. India with its Generic pharmaceuticals that will become one of the pillars of salvation for the NHS. This needs to happen now, before the Australian government (as well as the previous one) does something irreversibly stupid like signing the TPP. We must recognise here that it was not Australian Labor or the Australian Liberals asking the questions that had to be asked, it was New Zealand that put up a fight against the TPP issues. So have we been watching a media event by Martin Shkreli and Turing Pharmaceuticals?

Because we all need to realise clearly that once the TPP is signed, the signing government will have placed a knife on the throats of nearly 21.7% of the population of Australia, whilst that group will be left with no medical alternative!

That part reflects on the NHS!

When we consider some information from the ABPI (at http://www.abpi.org.uk/our-work/library/industry/Documents/OHE%20ABPI%20Medicines%20Bill%20Forecast.pdf), we must also acknowledge that they, the Association of the British Pharmaceutical Industry, represents commercial enterprises, a branch not to favoured, or flavoured towards generic medication. They are given, as I personally see it (read: speculate) the inside track from ‘friends’ on how far they must lower the price to remain seated. It is a form of let’s say branded exploitation that can no longer be afforded. Now, we must be clear that there is nothing illegal on branded exploitation, but we have to acknowledge that the NHS can no longer afford to play that game (a 2 billion deficit is ample proof of that).

Within the ABPI we see plenty of information, now consider this one quote from one of their presentations: “Loss of exclusivity of some major brands is projected to yield £3.4bn cumulative savings to the NHS between 2012 and 2015 with £5.4bn cumulative lost revenue to industry“. Do you think this is about the savings to the NHS, or the revenue lost to industry? If you think that this is about ‘savings to the NHS‘ than you, the respectful reader, will be slightly too naive than is good for you! I cannot fault the ABPI, because it is doing what it needs to do, represent its industry, we all forgot that they are not living in a symbiotic relationship with the government as they provide THEIR solutions to the NHS. The people the ABPI is representing, is a commercial group. They want to get the most out of whatever they can. Culling their needs by having stronger ties with Generic brands, even Indian ones is essential. They might cry about their low prices, but the reality is different. These players claiming the high costs are hoping you forget about news from 2001 (and many other years) where we saw “The UK government is introducing tax incentives aimed at persuading British-based pharmaceutical companies to boost their research into diseases affecting the world’s poor, such as AIDS, tuberculosis and malaria“, so they get the tax breaks for research, they have the inside tracks on ‘maximising’ product pricing solutions, yet overall they still complain. Which in light when we consider the ABPI document showing a 15% growth in spending on medication to be another issue. This is was a projection over 4 years (up to 2015), yet the facts remain, the NHS needs another solution and we agree that generic medication will not be as strong, however a medication that needs to be taken 10% longer might be preferable to medication that is 30% more expensive. Clarity is what matters here and for the implied accusation that Jeremy Hunt was keeping people in the dark should be offensive to all of us. There is one more side to all this, which is shown in that same presentation. The Office of Health Economics (OHE) is stating with their key message 6 that: “By 2015, new branded medicines launched between 2012 and 2015 will account for less than 2% of the total medicines bill. This underlies the issue in the UK of slow uptake of innovative new medicines“. From an analyst side I want to offer this thought to you. the quote ‘new branded medicines’ implies not that they are new medication, but new versions of existing medications, which means that rebranded and possibly marketed solutions is now implied to be below 2%, yet whatever deal is in place, it could also imply that this 2% is also a group that for now cannot be replaced by generic mediation. This is a speculation on my side, yet these kinds of presentations are never about ‘informing’ the people, it is about awareness on which questions to ask and what solutions to push for. Both tend to be expensive exercises for any NHS.

Yet medication is only one side, it is the one side we can clearly fight for with the possible reward of direct savings, but other sides need to be considered too. This we see in the comment article in the Guardian called ‘This junior doctor contract puts patients in danger‘ (at http://www.theguardian.com/commentisfree/2015/oct/04/junior-doctor-contract-patients-danger). Can anyone explain to me how the stupidity of “The contract that the Department of Health is threatening to impose on junior doctors once again raises the prospect of 90-hour weeks being written into rotas“? I went to University with some of these upcoming doctors, the pressure on them is just beyond harsh. How can a 90-hour contract be allowed? apart from that being a step just one hair fraction away from being regarded as slave labour, the pressures on these people will result in a certain harm to them self, an implied certain harm to their patients and a long term harm to the NHS as a whole. Because this will fall over within 2 years after which there will be no doctors left, there will be nearly no nurses left and the UK gets to rely on the medical care we can import from Siberia and Africa, how would that end well?

As a final year student in Intellectual Property law I call upon my peers to aid the NHS, give aid to them by creating strong patents for Generic medication, for patents that  lessen the stranglehold on prolonged exclusive medication. In 2008 in the Financial Times, Yusuf Hamied, stated: “I am not against patents, but India cannot afford them. I am against monopolies”, he is correct! In addition, now 7 years later the UK and many other nations cannot afford them either. That part has been ignored on many governmental levels all over the Commonwealth. The response the article gives: “he is a “pirate”, an opportunist who has exploited others’ intellectual property to swell his own profits. In the process, they say, he is undermining investment in future medicines, including the next generation of HIV therapies“, this fake response is flame baked with emotion, the reference to ‘the next generation of HIV therapies‘ does that. You see they had a patent, they had exclusivity for 20 years, but the people in that house became lazy and greedy and now they do not want to give it up. They try to revamp the drug to the tiniest part (they will call it an innovative new drug) and then they reshape it with a patent for 20 more years of exclusivity. They are now learning that this is not always successful. As a Patent Attorney (if I make it to the end) I would want to work on the patents of Generic medications, lowering the barricades to NHS on a global level, which is one of the reasons I oppose the TPP. Governments (including the UK) have squandered the position they had by prolonging a solution that never worked and voila, here we have the trillion pound deficit!

OK, I admit it is not a completely accurate statement and as such the issues are more complex, but we must fight the wars we can win and the NHS war could be won, however if Mr not so bright, I am hiding the numbers Jeremy Hunt MP is indeed hiding the numbers, any NHS solution will come too late, which puts 68 million in peril.

I feel that I am on the right track. Some will question my view towards Generic Medication Patents. When I consider my duties as stated in the Code of Conduct for Patent and Trade Marks Attorneys 2013, I see section 11 that a registered attorney must act as a patent attorney or a trade marks attorney in the following:

  • In accordance with the law; and
  • In the best interests of the registered attorney’s client; and
  • In the public interest; and
  • In the interests of the registered attorney’s profession as a whole.

The first two would carry for certain, the latter two are the debate. I believe that Generic Medication and protecting these is in the public interest on a global scale, I never believed that ‘reworking’ a patent, unless it is truly a new substance was in the public interest. You see exclusivity is a right given to the actual innovator, not giving in perpetuity, which only propagates exploitation, the last part is that the profession as a whole relies not on the cash of the rich client. It relies on driving true innovation, when we start repackaging the same solution with a new delivery method (which costs less than $15 dollars to make), the price hike from $20 to $175 is not just a tough pill to swallow it is a dangerous escalation in our greying population. The fact that Patent Laws as well as Patent Regulations have not been properly updated (even though this example is specifically for the US, not the UK) should give warning to other parts that needs to be overhauled.

This all hits back to the NHS. The Independent showed a few sides which reflects mighty badly on Jeremy Hunt. You see the quote: “it was his intention that no one should lose out financially” might sound nice and perhaps the change to a schedule where doctors work 7 days a week might not be an avoidable part, yet in all this the 90 hour a week part is still one of the deadliest issues. That person might not feel a financial ‘pinch’, but I guarantee you that these hours will drive most doctors bonkers within 2 years. How can the NHS survive when by 2018 23% of the medical GP’s are in a sanatorium? Did Mr Hunt add that risk to his spreadsheet?

So how will this end? Well, for Jeremy Hun MP not all that good I reckon (speculation on my side), but we have to wait to see all the facts to place judgment on this. In all this, as I see it, I started with the title: ‘How to cure economic sickness‘.

The answer in my case is by changing direction, by changing it massively. There is now more than half a decade of data and Business Intelligence that the US only considers the US and there they falter and fail as they refuse to deal with Greed. They hide behind more and more emotional stories (especially when there are school shootings), even there the US legislative branch is failing its people. The Commonwealth cannot afford these steps. We the Commonwealth must unite as never before. We the people of the Commonwealth must also realise that to make this work we must be willing to make large changes if needed. I always lived a global live, so if I am required to move to the UK, Canada or perhaps even India, than I will! In this day and age, holding onto your one little hill (especially those with tertiary educations) we must consider a global (read a complete Commonwealth field). The UK must start to realise this too, because they have squandered too much funds on solutions that never worked. Australia is moving into that direction as well as Canada, they just move in that direction more politely than the other players.

And finally my message to David Cameron. David, your Conservative party can be the solution, we all can be part of that solution, yet in all this we must know how bad things are and the playbook you currently use needs to change, the US can no longer be seen as a potential ‘solution’, they burned that bridge by themselves. Our Commonwealth can grow towards the empire it was, we have the skills, we have the innovators, we have the drive and (most of us) the loyalty to the crown, yet in all this, not enough drive towards a Commonwealth Union has been made. The SNP is partially evidence of that. They now realise that their oil revenue is not making it work, they need to realise that together we are stronger. Yes, perhaps that will be as an independent Scotland, but then it should still be a Commonwealth Nation, we must propel on all sides to show both the US and China that the UK is the 5th largest economy, yet as a United Commonwealth we can surpass China and become the second largest economy! The next 12 years will be about the innovators that propel ideas in many fields. We will see a growth in Trade Marks, in Patents and in Business solutions and all this will be resulting in new avenues of growth, yet as a single nation the UK can no longer compete to the extent it needs to. The costs are too high, the NHS is the first and clearest piece of evidence.

So economic sickness can be cured, it needs the right medication and this can be administered by acquiring the right medication, the current providers have shown that they are not up to the task!

I leave it to the honourable David Cameron to set the right course!

Leave a comment

Filed under Uncategorized

In Greed we trust

In greed we trust, all others are expected to die! That is the basic setting which is now ruling the internet and it all started when the CEO of Turing Pharmaceuticals AG bought the rights to generic drug Daraprim and he subsequently raised the price by 5500%. This now creates two parts. They are:

  1. How is this legal?
  2. How to prevent such dangerous situations?

The initial part is not found. You see, when we look at the definition of Financial Exploitation, we get: “Financial exploitation occurs when a person misuses or takes the assets of a vulnerable adult for his/her own personal benefit. This frequently occurs without the explicit knowledge or consent of a senior or disabled adult, depriving him/her of vital financial resources for his/her personal needs” (source:  National Adult Protective Services Association (NAPSA)). Most forms of protection against exploitation is against what people own. One of the most famous cases in Australia is Commercial Bank of Australia v Amadio (1983) 151 CLR 447; [1983] HCA 14. Yet, the law regarding exploitation of something that is not owned is not clear, in certain places we see that in the Generics and Biosimilars Initiative Journal (GaBI Journal). 2012;1(3-4):146-9. The title of the PPRI conference reports gives us this with ‘The potential of generics policies: more room for exploitation’. The tactic is quite sound, if the price of normal medication cannot be lowered, than raising the price of generics is a sound strategy from the view of the greedy. The paper also gives us “Mr Richard Bergstrom, President of the European Federation of Pharmaceutical Industries and Associations stated that ‘once patents expire, prices should fall to a low, but sustainable, level’. In this panel discussion but also throughout the conference there appeared to be a common understanding that generics competition works well”. This was a view stated almost 3 years ago, which is true. However, the solutions that are addressed to a 2% or even 1% market does not seem to have too many alternatives, this is where the solutions like Daraprim and Cycloserine seem to come into play. The older small solutions that have no equal because the need is too small, now a massive option for larger profits.

When we look at Bloomberg on August 6th, we get: “Allergan Plc’s Actavis unit got a subpoena from the U.S. Justice Department seeking information on the marketing and prices of its generic drugs, becoming the biggest company yet to draw scrutiny in the government’s widening antitrust probe of the industry. The June 25 subpoena also sought information about communications with competitors regarding the products, Allergan said Thursday in a filing. While the company didn’t supply further information and didn’t specify the competitors, rivals including Lannett Co., Endo International Plc, Par Pharmaceutical Holdings Inc. and Impax Laboratories Inc. have made similar disclosures in the past several months“, as well as “Some 10 percent of generic drugs doubled in price between July 2013 and June 2014, and half of all generic drugs rose in price, according to an analysis earlier this year of Centres for Medicare and Medicaid data cited by Senator Bernie Sanders, an independent from Vermont who’s running for president, and Representative Elijah Cummings, a Democrat from Maryland

So as we see these events, why did Martin Shkreli make this move? An entrepreneur of his achievements does not play around. What is his game?

The ‘defence’ we see from the other side is “Shkreli said: “We need to turn a profit on the drug.” He defended the decision by telling Bloomberg News that newer versions of the drug needed to be developed and his was the first company “to really focus on this product” for decades and that such research was extremely expensive“. This goes against the statement he later makes, which was “He also promised that: “If you cannot afford the drug we will give it away for free.” Shkreli also said the drug was currently under priced” (source: http://www.theguardian.com/business/2015/sep/21/entrepreneur-defends-raise-price-daraprim-drug).

Now we have an issue with all this. Is this about the medication, or is this a first step to bleed dry health systems?

For this we must show one additional quote. It is “Shkreli’s start-up company, Turing Pharmaceuticals, acquired Daraprim in August. The drug was first developed in the 1940s and is used to treat toxoplasmosis, an infection that is not common but is particularly dangerous and can be fatal“. The question in my mind is how this existing drug is any form of treatment against the complications of AIDS? A drug that is over 60 years old, which is suddenly the foundation towards a cure? What are we not seeing? Well, that part is shown by CNBC (at http://www.cnbc.com/2015/09/21/drug-prices-big-price-increase-for-daraprim-rescinded.html). Here we see that this is the second act. The first one was “Cycloserine was acquired last month by Rodelis Therapeutics, which promptly raised the price to $10,800 for 30 capsules, from $500. But the company agreed to return the drug to its former owner, a non-profit organization affiliated with Purdue University, the organization said on Monday“, after which the price ‘stabilised’ at twice the original price. So is this about a changing approach to the increase of generic medication by 100%-300% in the end? In addition, the other CNBC quote is “However, outrage over a gigantic price increase for another drug spread into the political sphere on Monday, causing biotechnology stocks to fall broadly as investors worried about possible government action to control pharmaceutical prices. The Nasdaq Biotechnology Index fell more than 4 percent“, now this is all starting to make sense. A hedge funds manager playing the market and playing the waves of market exploitation. This is not unheard of, more important, for the most, we could argue that no illegal acts were undertaken. The Guardian stated “It is not uncommon for companies to use inventive interpretations of government regulations and loopholes in the law to corner the market for certain drugs, especially ones that were developed a long time ago and have only a limited market“, which is true, but when we considered the additional event that the Guardian ignored, give us cause for concern. I am not stating that the Guardian is trying to misinform its readers, their conclusion on one case is sound. Yet, when we see the addition that came from CNBC regarding Rodelis Therapeutics, we see another side. Here we see a side of market exploitation and Market manipulation, as far as I can tell at present in a very legal way. That we see from “Mr. Hasler said the new price was needed to stem losses”. Really? So is this about feigned losses, or is this one of many steps where drugs that treat smaller populations to grow 100%-300% in price to assure a market niche that most NHS systems (US, EEC and Commonwealth nations) are unable to fight. In this way on an international level the respected NHS versions will be placed under additional pressure. As I see it, Martin Shkreli has started Turing Pharmaceuticals AG to dig into this very profitable branch. In addition, for something this expensive, how come those rights transferred for only 55 million?

It seems to me that parts in all this remains unstated. Why?

Now in this part I am not having a go at journalists as in the past. For one, this is an evolving story, in the second part there are a few sides to all this. For one, I am speculating in what the game is here (speculating is not now, nor should it ever be regarded as factual). In addition there are sides that have not played yet. One of these sides is the law. As I personally see it, certain entrepreneurs, wealthy or not are now trying to corner the 2% treatment solutions, perhaps even the one percent group. Consider how this affects the UK. Let’s use the UK statistics. When we consider 240 million patients a year. If 2.4 million people require a drug and if that price suddenly goes up from $500 to $1000 (the Cycloserine example). This is only in the UK. Which gives them an additional 1.2 billion and this is only ONE nation, now consider the effect on the EEC as well as the US and the other Commonwealth nations, now the money becomes really handsome. Even at 0.1% it is a massive influx of money and for now all very legal. I have full faith that the law will be adjusted, yet we will see that it will be adjusted too late and some of these fast moving rascals will have made a massive additional amount of money, which is not an illegal act by the way.

This whilst I am still slaving over my issues of Infringement. That and a massive student loan will not propel me whilst some dubious hedge funds individual walks away with billions. A clever mind is half the battle!

So as this event escalates, the UK will have a new problem, because as is, the prospect stated ‘Planned NHS expenditure for 2015/16 is £116.574bn‘ is possible off by no less than 10%, the generic pharma side is only one side. I wonder what happens when these ‘entrepreneurs’ acquire the service contracts of hospitals at large, what happens when the MRI contracts are sold off to third parties? What happens when those prices go up? This is a path that Stadium Group CEO Charlie Peppiatt seems to be walking towards in a very successful way. As one third of the planet goes into ‘one foot in the grave mode’ that population will require a massive amount of support in medical terms (until they move towards their respective casket or urn). There is one side that is an issue for the other players. As I see it Martin Shkreli might be the most visible one but as I see it not the brightest (massively richer than me though), in one bash he has given visibility to a move that many wanted to keep under wraps, because out of sight, out of mind and that would have resulted in profits (loads of it). The visibility forced on the eyes of many might now result in NHS safety valves that could stop the forced squandering of funds. I wonder if my view is correct and more important will proper steps be taken sooner rather than later.

I’ll let you decide.

 

1 Comment

Filed under Finance, Law, Media, Science